Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Subclinical Hypothyroidism Overdiagnosis in Pregnant Women—Reply
Maraka, Spyridoula , Ospina, Naykky Singh , Montori, Víctor M. , Ospina, Naykky Singh , Maraka, Spyridoula , Montori, Victor M , Singh Ospina, Naykky M , Singh Ospina, Naykky

JAMA Internal Medicine | November 2, 2015 | Volume: 175 | Issue: 11 | Pages: 1873

10.1001/jamainternmed.2015.5553 | PMID 26524759 Get It

Physiology in Perspective: Why Do We Continue to Ignore Sex Differences?
Sieck, Gary C. , Sieck, Gary

Physiology | November 2, 2015 | Volume: 30 | Issue: 6 | Pages: 406-407

10.1152/physiol.00044.2015 | PMID 26525339 Get It

Cancer Bioinformatic Methods to Infer Meaningful Data from Small-Size Cohorts
Bennani-Baiti, Nabila, Bennani-Baı̈ti, Idriss M.

Cancer Informatics | November 2, 2015 | Volume: 14 | Issue: No issue available | Pages: CIN.S32696

10.4137/cin.s32696 | PMID 26568679 Get It

Whole-genome analyses have uncovered that most cancer-relevant genes cluster into 12 signaling pathways. Knowledge of the signaling pathways and associated gene signatures not only allows us to understand the mechanisms of oncogenesis inherent to specific cancers but also provides us with drug targets, molecular diagnostic and prognosis factors, as well as biomarkers for patient risk stratification and treatment. Publicly available genomic data sets constitute a wealth of gene mining opportunities for hypothesis generation and testing. However, the increasingly recognized genetic and epigenetic inter- and intratumor heterogeneity, combined with the preponderance of small-size cohorts, hamper reliable analysis and discovery. Here, we review two methods that are used to infer meaningful biological events from small-size data sets and discuss some of their applications and limitations.
Regenerative ophthalmology: Technologic and pharmacologic approaches to restoring sight via retinal prosthesis
Iezzi, Raymond

Clinical Pharmacology & Therapeutics | November 2, 2015 | Volume: 99 | Issue: 1 | Pages: 33-35

10.1002/cpt.292 | PMID 26522735 Get It

Retinal prosthesis technology can restore rudimentary form vision in patients with retinitis pigmentosa (RP) who have lost all eyesight. This continually advancing field within regenerative ophthalmology represents the merger of micro‐electromechanical systems technology with neurosensory retina. This man‐machine interface is reliant upon the long‐term health of a neurosensory retina undergoing progressive pathophysiologic changes. Pharmacologic approaches that address the pathophysiologic consequences of RP will likely play an important role for all regenerative treatment strategies.
Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer
Vargas, Carlos , Hartsell, William F. , Dunn, Megan, Keole, Sameer R., Doh, Lucius, Eisenbeisz, Elaine, Larson, Gary, Dunn, Megan

American Journal of Clinical Oncology | October 31, 2015 | Volume: 41 | Issue: 2 | Pages: 115-120

10.1097/coc.0000000000000241 | PMID 26523442 Get It

Objective: To identify differences in terms of quality of life, the American Urological Association Symptom Index (AUA), or adverse events (AEs) among patients with prostate cancer treated with either standard fractionation or hypofractionation proton-beam therapy. Materials and Methods: Patients were prospectively randomized to receive 38 Gy relative biological effectiveness (RBE) in 5 treatments (n=49) or 79.2 Gy RBE in 44 treatments (n=33). All patients had low-risk prostate cancer and were treated with proton therapy using fiducial markers and daily image guidance. Results: Median follow-up for both groups was 18 months; 33 patients had follow-up of 2 years or longer. Baseline median (range) AUA was 4.7 (0 to 13) for the 38 Gy RBE arm and 4.8 (0 to 17) for the 79.2 Gy RBE arm. We observed no difference between the groups regarding the Expanded Prostate Index Composite urinary, bowel, or sexual function scores at 3, 6, 12, 18, or 24 months after treatment. The only significant difference was the AUA score at 12 months (8 for the 38 Gy RBE arm vs. 5 for the 79.2 Gy RBE arm; P=0.04); AUA scores otherwise were similar between groups. No grade 3 or higher AEs occurred in either arm. Conclusions: Patients treated with proton therapy in this randomized trial tolerated treatment well, with excellent quality-of-life scores, persistent low AUA, and no grade 3 or higher AEs on either arm. We showed no apparent clinical difference in outcomes with hypofractionated proton-beam therapy compared with standard fractionation on the basis of this interim analysis.
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts
Caviness, John N., Utianski, Rene L. , Hentz, Joseph G. , Beach, Thomas G. , Dugger, Brittany N. , Shill, Holly A. , Driver‐Dunckley, E. D., Mehta, Shyamal H. , Driver‐Dunckley, Erika , Sabbagh, Marwan Noel , Adler, Charles H. , Utianski, Rene L , Dugger, Brittany N

European Journal of Neurology | October 31, 2015 | Volume: 23 | Issue: 2 | Pages: 387-392

10.1111/ene.12878 | PMID 26518336 Get It

Background and purposeIt is believed that progressive Lewy‐type synucleinopathy (LTS) is primarily responsible for the worsening of motor and non‐motor Parkinson's disease (PD) signs and symptoms. Characterization of quantitative electroencephalography (QEEG) abnormalities across the spectrum of LTS to PD dementia (PD‐D) may provide insight into the pathophysiology of PD cortical dysfunction. Here our enlarged EEG database was leveraged to characterize spectral QEEG abnormalities in asymptomatic autopsy‐defined groups of control participants and incidental Lewy body disease (ILBD) and three clinically defined groups of participants with PD (cognitively normal PD, mild cognitive impairment PD, and PD‐D).MethodsThe PD cohort was studied as part of the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND). AZSAND utilizes its Brain and Body Donation Program to perform prospective, standardized, regular longitudinal pre‐mortem assessments until death. Resting EEG from subjects was analyzed for spectral domain QEEG measures of background rhythm frequency and global relative power in delta, theta, alpha and beta bands.ResultsThe various spectral QEEG measures showed differential changes specific to the groups compared. Important findings were background rhythm frequency showing the most pairwise differences across the groups, and this also was the only significant difference between control and ILBD. An increase in delta bandpower was characteristic of worsening cognitive deficits.ConclusionsDifferent patterns of change amongst QEEG measures across LTS and PD cognitive states suggest that they correlate with heterogeneous pathophysiologies of cortical dysfunction within the PD clinical spectrum. In addition, the biomarker application of a specific spectral QEEG measure needs to be selectively suited to its study purpose.
Practice improvement requires more than guidelines and quality measures
Sigsbee, Bruce, Bever, Christopher T. , Jones, Lyell K. , Jones, Lyell K

Neurology | October 31, 2015 | Volume: 86 | Issue: 2 | Pages: 188-193

10.1212/wnl.0000000000002116 | PMID 26519541 Get It

β-Glucan–Activated Human B Lymphocytes Participate in Innate Immune Responses by Releasing Proinflammatory Cytokines and Stimulating Neutrophil Chemotaxis
Ali, Mohamed F. , Driscoll, Christopher B. , Walters, P. , Carmona, Eva M. , Walters, Paula R, Limper, Andrew H. , Carmona, Eva M , Driscoll, Christopher

The Journal of Immunology | October 31, 2015 | Volume: 195 | Issue: 11 | Pages: 5318-5326

10.4049/jimmunol.1500559 | PMID 26519534 Get It

Abstract B lymphocytes play an essential regulatory role in the adaptive immune response through Ab production during infection. A less known function of B lymphocytes is their ability to respond directly to infectious Ags through stimulation of pattern recognition receptors expressed on their surfaces. β-Glucans are carbohydrates present in the cell wall of many pathogenic fungi that can be detected in the peripheral blood of patients during infection. They have been shown to participate in the innate inflammatory response, as they can directly activate peripheral macrophages and dendritic cells. However, their effect as direct stimulators of B lymphocytes has not been yet fully elucidated. The aim of this study was to examine the molecular mechanisms and cytokine profiles generated following β-glucan stimulation of B lymphocytes, compared with the well-established TLR-9 agonist CpG oligodeoxynucleotide (CpG), and study the participation of β-glucan–stimulated B cells in the innate immune response. In this article, we demonstrate that β-glucan–activated B lymphocytes upregulate proinflammatory cytokines (TNF-α, IL-6, and IL-8). Of interest, β-glucan, unlike CpG, had no effect on B lymphocyte proliferation or IgM production. When compared with CpG (TLR9 agonist), β-glucan–activated cells secreted significantly higher levels of IL-8. Furthermore, IL-8 secretion was partially mediated by Dectin-1 and required SYK, MAPKs, and the transcription factors NF-κB and AP-1. Moreover, we observed that conditioned media from β-glucan–stimulated B lymphocytes elicited neutrophil chemotaxis. These studies suggest that β-glucan–activated B lymphocytes have an important and novel role in fungal innate immune responses.
Immunophenotypic and cytogenetic findings of B‐lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement
Kelemen, Katalin, Holden, Jaclyn, Johnson, Laura J., Davion, Simone, Robetorye, Ryan S.

Cytometry Part B: Clinical Cytometry | October 30, 2015 | Volume: 92 | Issue: 4 | Pages: 310-314

10.1002/cyto.b.21334 | PMID 26517296 Get It

BackgroundB‐lymphoblastic leukemias (B‐LBL) with combined IGH/BCL2 and MYC rearrangement are rare and their clinical, cytogenetic and immunophenotypic features are not well characterized. Here, we describe a case of a 61‐year‐old woman with B‐LBL associated with these cytogenetic alterations and present a review of the literature of this disease.MethodsFour‐color flow cytometry (FC) was performed on a BD FACSCanto II flow cytometer. Data were analyzed with BD FACSDiva software. Cytogenetic, fluorescence in situ hybridization (FISH), and molecular studies were performed by conventional methods. A review of the literature was performed by a PubMed‐assisted search.ResultsIncluding our case, eight B‐LBLs associated with a documented “double‐hit” karyotype (IGH/BCL2 and 8q24/MYC rearrangement) were identified in the literature (male/female 2/6, age 15‐65). Three occurred de‐novo, and five had a history of a CD10+ B‐cell lymphoma. The typical immunophenotype was CD10, CD19, TdT positive, and negative for CD34 and surface immunoglobulin (Ig), established either by FC or immunohistochemistry. Seven cases were CD20‐, and one case was CD20+. Translocation partners of MYC varied, and included IGH, lambda light chain, and an unknown gene on chromosome 9. Prognosis was poor with median survival of five months.ConclusionsPatients with B‐LBL associated with a combined IGH/BCL2 and MYC rearrangement often have a history of a mature B‐cell lymphoma. The immunophenotype of these cases is different from that of mature “double‐hit” lymphomas; FC is essential to differentiate the B‐LBL cases from the leukemic phase of mature B‐cell lymphomas. © 2015 International Clinical Cytometry Society
The Impact of Prior Radiation Therapy on Artificial Urinary Sphincter Device Survival
Rivera, Marcelino , Linder, Brian J. , Ziegelmann, Matthew , Viers, Boyd R. , Rangel, Laureano J. , Elliott, Daniel S. , Rivera, Marcelino E, Ziegelmann, Matthew J, Linder, Brian J , Viers, Boyd R

Journal of Urology | October 30, 2015 | Volume: 195 | Issue: 4 Part 1 | Pages: 1033-1037

10.1016/j.juro.2015.10.119 | PMID 26518111 Get It